Myocardial Infarction

  • Abhishek Kumar Singh
  • Rakesh Kumar Jat

Abstract

Myocardial infarction (MI), commonly known as a heart attack is the disease of the blood vessels supplying the heart muscle (Myocardium) i.e. coronary heart disease. The area of heart muscle that has either zero flow or so little flow that it cannot sustain cardiac muscle function is said to be infracted and the overall process is called a myocardial infarction. MI are of two types; transmural and subendocardial. Mainly it is caused due to oxidative stress and atherosclerosis.Chest pain is the most common symptom of acute MI and is often described as a sensation of tightness, pressure, or squeezing. Other symptoms include diaphoresis (an excessive form of sweating), Shortness of breath (dyspnea), weakness, light-headedness, nausea, vomiting, and palpitations. The most common symptoms of MI in women include dyspnea, weakness, and fatigue, sleep disturbances. It can be treated by using  blockers, diuretics, ACE inhibitors, calcium channel blockers and nitrates.

Keywords: Myocardial Infarction, Atherosclerosis, Transmural, Subendocardial, Oxidative Stress

References

1. Mohan H. Textbook of Pathophysiology. 5th Ed. New Delhi: Jaypee Brothers medical publishers (p) ltd; 2005.
2. Robert Beaglehole, et al. The World Health Report 2004 - Changing History. World Health Organization; 2004. pp. 120–4.
3. "Cause of Death - UC Atlas of Global Inequality". Center for Global, International and Regional Studies (CGIRS) at the University of California Santa Cruz; 2006 Dec 7
4. "Deaths and percentage of total death for the 10 leading causes of death: United States, National Center of Health Statistics; 2002-2003
5. Mukherjee AK. (1995). "Prediction of coronary heart disease using risk factor categories". J Indian Med Assoc 93 (8): 312–5. PMID 8713248.
6. Ghaffar A, Reddy KS and Singhi M. "Burden of non-communicable diseases in South Asia". BMJ. 2004; 328 (7443): 807–810.
doi:10.1136/bmj.328.7443.807. PMID 15070638.
7. Rastogi T, Vaz M, Spiegelman D, Reddy KS, Bharathi AV, Stampfer MJ, Willett WC and Ascherio1 A. "Physical activity and risk of coronary heart disease in India". Int. J. Epidemiol. 2004;33(4):1-9.
doi:10.1093/ije/dyh042. PMID 15044412
8. Gupta R. "Escalating Coronary Heart Disease and Risk Factors in South Asians". Indian Heart Journal.2007;214-17.
9. Gupta R, Misra A, Pais P, Rastogi P and Gupta VP. "Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factors" (PDF). International Journal of Cardiology. 2006; 108(3):291–300. Doi: 10.1016/j.ijcard.2005.05.044. PMID15978684.
10. Workers' Compensation FAQ. Prairie View A&M University. 2006 Nov 22.
11. SIGNIFICANT DECISIONS Subject Index. Board of Industrial Insurance Appeals; 2006 Nov 22
12. "Classification of Drivers' Licenses Regulations". Nova Scotia Registry of Regulations; 2000 May 24.
13. Harrison DG, Dikalov S. Oxidative events in cell and vascular biology. In: Re RN, DiPette DJ, Schriffrin EL, et al, editors. Molecular mechanisms in hypertension. 1st edition. Abingdon (UK): Taylor & Francis Medical Books; 2006.
14. Duthie GG, Wahle KWJ, James WPT. Oxidants, antioxidants and cardiovascular disease. Nutrition Research Reviews. 1989;2:51-62.
15. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS, et al. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 2002;34:379-388.
16. David GH, Maria CG. Oxidative Stress and Hyper tension. Med. Clin. N. 2009;93:621-635.
17. Scandalios JG. Oxidative stress responses- what have genome-scale studies taught us? Genome Biology. 2002; 3(7):1019.1-1019.6
18. Wassmann S, Wassmann K, Nickenig G. Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease. Curr Hypertens Rep. 2006;8(1):69-78.
19. Mainzen PS, Karthick M. Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in ISO-induced myocardial infarction in rats. Preventive Effect of Rutin on Lipids, Lipoproteins, and ATPases in Normal and Isoproterenol-Induced Myocardial Infarction in Rats. J Biochem Molecular Toxicology. 2007;21;1: 701-707.
20. Stocker R, Keaney FK. Oxidative stress and atherosclerosis. In: Loscalzo J. editor; Molecular mechanisms of atherosclerosis. London and New York: Taylor & Francis Group Pvt ltd; 2005. p. 83-114.
21. Gaetani G, Ferraris A, Rolfo M, Mangerini R, Arena S, Kirkman H, et al. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood. 1996; 87(4):1595-1599.
22. Allen PB, Renu V. Pathophysiology of Acute Myocardial Infarction. Med Clin N Am. 2007;91:553-572.
23. Prof. Roger G. Mark. Clinical Electrocardiography and Arrhythmias. Massachusetts Institute of Technology. Quantitative Physiology: Organ Transport Systems. 2004:1-7.
24. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ, et al. Women's early warning symptoms of acute myocardial infarction. Circulation. 2003; 108(21): 2619-23.
25. Kannel WB. Silent myocardial ischemia and infarction: insights from the Framingham Study. Cardiol. Clin. 1986;4(4):583-91.
26. Davis TM, Fortun P, Mulder J, Davis WA, Bruce DG. Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study. Diabetologia. 2004; 47(3):395-399.
27. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. "Prediction of coronary heart disease using risk factor categories". Circulation. 1998;97(18):1837-47. PMID 9603539.
28. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. "Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study". Ann Intern Med. 1992; 116(4):273-8. PMID 1733381.
29. Andraws R, Berger JS, Brown DL. "Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials". JAMA. 2005;293 (21):2641-7.
doi:10.1001/jama.293.21.2641. PMID 15928286.
30. Muller JE, Stone PH, Turi ZG, et al. "Circadian variation in the frequency of onset of acute myocardial infarction". N. Engl. J. Med. 1985;313 (21):1315-22. PMID 2865677
31. Beamer AD, Lee TH, Cook EF, et al. "Diagnostic implications for myocardial ischemia of the circadian variation of the onset of chest pain". Am. J. Cardiol. 1987; 60(13):998-1002.
doi:10.1016/0002-9149(87)90340-7. PMID 3673917.
32. Cannon CP, McCabe CH, Stone PH, et al. "Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)". Am. J. Cardiol. 1997; 79(3):253-8.
doi:10.1016/S0002-9149(97)00743-1.
33. Tofler GH, Brezinski D, Schafer AI, et al. "Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death". N. Engl. J. Med. 1987;316(24):1514-8.
PMID 3587281.
34. Fantidis P, Perez De Prada T, Fernandez-Ortiz A, et al. "Morning cortisol production in coronary heart disease patients". Eur. J. Clin. Invest. 2002;32(5):304–8.
doi:10.1046/j.1365-2362.2002.00988.x. PMID 12027868.
35. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. "Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study". Lancet 2005;366(9497):1640-9.
doi:10.1016/S0140-6736(05)67663-5.PMID16271645
36. Barar FSK. Essentials of Pharmacotherapeutics. 3rd Ed. New Delhi: S. Chand; 2004.
37. Thandroyen FT, Bellotto D, Katayama A, Hagler HK, Willerson JT and Buja LM et al. Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes. Circulation Research. 1992; 71(1):106-119.
38. Vandana SP, Suresh RN. Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: A biochemical and histoarchitectural evaluation. Experimental and Toxicologic Pathology. 2008; 60:397-404.
39. Stanley WC. Cardiac energetics during ischaemia and the rationale for metabolic interventions. Coron Artery Dis. 2001; 12 Suppl 1:S3-7.
40. Virmani R, Forman MB, Kolodgie FD. Myocardial reperfusion injury. Histopathological effects of perfluorochemical. Circulation. 1990; 81(3 Suppl IV):57-68.
41. Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 2005; 14(4):170-5.
42. Krijnen PA, Nijmeijer R, Meijer CJ, Visser CA, Hack CE, Niessen HW. "Apoptosis in myocardial ischaemia and infarction". J Clin Pathol. 2002; 55 (11):801-11. doi:10.1136/jcp.55.11.801. PMID 12401816
43. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am. Heart. J. 1984; 108:150-158.
44. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Cell Cardiol. 2000; 36(3):959-69.
45. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, et al. Harrison’s Principles of Internal Medicine, Vol II, 16th Ed. New Delhi: McGraw-Hill Medical Publishing Division; 2005.
46. Goldschlager N, Gold man MJ. Principles of Clinical Electrocardiography. 13th ed. New Delhi: McGraw Hill Co-Inc.; 1989.
47. Prof. Roger G. Mark. Clinical Electrocardiography and Arrhythmias. Massachusetts Institute of Technology. Quantitative Physiology: Organ Transport Systems. 2004:1-7.
48. Davey P. ECG. Medicine. 2006; 34(4):128-135.
49. Ross GE, Bever F, Uddin Z, Devireddy L, Gardin J. Common scenarios to clarify the interpretation of cardiac markers. J. Am. Osteopath. Assoc. 2004; 104(4):165-176.
50. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J. Am. Coll. Cardiol. 2002; 40:1366-1374.
51. Boonprasert P, Lailerd N, Chattipakorn N. Urocortins in heart failure and ischemic heart disease. Int. J. Cardiol. 2008; 127:307-312.
52. Cruz-Gonzalez I, Pabon P, Rodriguez-Barbero A, Martin-Moreiras J, Pericacho M, Sanchez PL et al. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J.Cell.Mol.Med. 2008; 12(3):955-961.
53. Rubin's Pathology - Clinicopathological Foundations of Medicine. Maryland: Lippincott Williams & Wilkins. 2001. p.546. ISBN 0-7817-4733-3
54. Eichbaum FW. "'Wavy' myocardial fibers in spontaneous and experimental adrenergic cardiopathies" Cardiology 1975; 60(6): 358–65. PMID 782705.
55. S Roy. Myocardial infarction. Retrieved November 28, 2006.
56. Fishbein MC. "Reperfusion injury". Clin Cardiol. 1990; 13(3):213-7. doi:10.1152/ajpheart.00270.2002
57. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-77.
58. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-21. [Erratum, N Engl J Med 2003;348:2271.]
59. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts.Circ Res. 1990;66:883-90.
Statistics
1602 Views | 1247 Downloads
How to Cite
Kumar Singh, A., and R. Kumar Jat. “Myocardial Infarction”. Himalayan Journal of Health Sciences, Vol. 6, no. 4, Jan. 2022, pp. 16-32, doi:10.22270/hjhs.v6i4.116.
Section
Review Article (s)